
Cano Health, Inc. – NYSE:CANO
Cano Health stock price monthly change
Cano Health stock price quarterly change
Cano Health stock price yearly change
Cano Health key metrics
Market Cap | 12.43M |
Enterprise value | 1.53B |
P/E | -1.69 |
EV/Sales | 0.74 |
EV/EBITDA | 31.45 |
Price/Sales | 0.17 |
Price/Book | 1.42 |
PEG ratio | N/A |
EPS | -248.71 |
Revenue | 3.10B |
EBITDA | -291.38M |
Income | -731.11M |
Revenue Q/Q | 18.50% |
Revenue Y/Y | 21.60% |
Profit margin | -2.86% |
Oper. margin | -3.1% |
Gross margin | 15.3% |
EBIT margin | -3.1% |
EBITDA margin | -9.39% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCano Health stock price history
Cano Health stock forecast
Cano Health financial statements
Dec 2022 | 680.37M | -301.72M | -44.35% |
---|---|---|---|
Mar 2023 | 866.90M | -28.15M | -3.25% |
Jun 2023 | 766.74M | -140.75M | -18.36% |
Sep 2023 | 788.07M | -260.48M | -33.05% |
2025 | 3.34B | -87.16M | -2.6% |
---|
Analysts Price target
Financials & Ratios estimates
2023-11-09 | -18.5 | -91.87 |
---|---|---|
2024-03-06 | -17.56 | 18 |
Payout ratio | 0% |
---|
2019 | 0.14% |
---|---|
2020 | 4.76% |
2021 | |
2022 |
Dec 2022 | 1928927000 | 1.43B | 74.38% |
---|---|---|---|
Mar 2023 | 1944376000 | 1.43B | 74.06% |
Jun 2023 | 1707322000 | 1.47B | 86.19% |
Sep 2023 | 1211931000 | 1.47B | 121.38% |
Dec 2022 | -62.17M | -16.00M | 81.41M |
---|---|---|---|
Mar 2023 | -29.47M | -9.45M | 56.48M |
Jun 2023 | -15.48M | -8.24M | 6.56M |
Sep 2023 | -39.71M | 26.54M | 26.77M |
Cano Health alternative data
Aug 2023 | 4,365 |
---|---|
Sep 2023 | 4,118 |
Oct 2023 | 4,118 |
Nov 2023 | 4,118 |
Dec 2023 | 4,010 |
Jan 2024 | 4,010 |
Feb 2024 | 4,010 |
Mar 2024 | 4,010 |
Apr 2024 | 4,010 |
May 2024 | 4,010 |
Jun 2024 | 4,010 |
Jul 2024 | 4,010 |
Cano Health other data
Period | Buy | Sel |
---|---|---|
Apr 2023 | 13528743 | 47081077 |
Jun 2023 | 0 | 1829103 |
Aug 2023 | 0 | 30646 |
Dec 2023 | 0 | 251599 |
Jan 2024 | 0 | 998841 |
Feb 2024 | 0 | 1100 |
Quarter | Transcript |
---|---|
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 10 May 2023 | Q1 2023 Earnings Call Transcript |
Q4 2022 1 Mar 2023 | Q4 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Marlow Hernandez Cano (1985) Founder, Chief Executive Officer, Pres & Chairman | $1,050,000 |
Dr. Richard B. Aguilar M.D. (1956) Chief Clinical Officer | $350,000 |
Mr. David J. Armstrong Esq., J.D. (1965) Gen. Counsel, Chief Compliance Officer & Sec. | $305,000 |
Cano Health: The Near Term Is Dismal, But The Long Term Is Bright
P3 Health Partners Reaffirms 2022 Growth Over 61% And Path To Profitability
Cano Health: FY23 Could Be A Better Year
Am I Wrong About CVS?
Cano Health: An Unappreciated Gem And Potential 10-Bagger
Cano Health: 75% Off Sale
CVS Health: Future Is Healthy
Walgreens: Potential Risks And Rewards Heading Into Q4 FY22 Earnings
Insider Weekends: Return Of The Meme Stocks - GameStop And AMC Entertainment
-
When is Cano Health's next earnings date?
Unfortunately, Cano Health's (CANO) next earnings date is currently unknown.
-
Does Cano Health pay dividends?
No, Cano Health does not pay dividends.
-
How much money does Cano Health make?
Cano Health has a market capitalization of 12.43M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 70.19% to 2.74B US dollars. Cano Health made a loss 428.39M US dollars in net income (profit) last year or $18 on an earnings per share basis.
-
What is Cano Health's stock symbol?
Cano Health, Inc. is traded on the NYSE under the ticker symbol "CANO".
-
What is Cano Health's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of Cano Health?
Shares of Cano Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cano Health's key executives?
Cano Health's management team includes the following people:
- Dr. Marlow Hernandez Cano Founder, Chief Executive Officer, Pres & Chairman(age: 40, pay: $1,050,000)
- Dr. Richard B. Aguilar M.D. Chief Clinical Officer(age: 69, pay: $350,000)
- Mr. David J. Armstrong Esq., J.D. Gen. Counsel, Chief Compliance Officer & Sec.(age: 60, pay: $305,000)
-
Is Cano Health founder-led company?
Yes, Cano Health is a company led by its founder Dr. Marlow Hernandez Cano.
-
How many employees does Cano Health have?
As Jul 2024, Cano Health employs 4,010 workers.
-
When Cano Health went public?
Cano Health, Inc. is publicly traded company for more then 5 years since IPO on 2 Jul 2020.
-
What is Cano Health's official website?
The official website for Cano Health is canohealth.com.
-
Where are Cano Health's headquarters?
Cano Health is headquartered at 9725 NW 117th Avenue, Miami, FL.
-
How can i contact Cano Health?
Cano Health's mailing address is 9725 NW 117th Avenue, Miami, FL and company can be reached via phone at +855 2266633.
Cano Health company profile:

Cano Health, Inc.
canohealth.comNYSE
4,010
Medical - Care Facilities
Healthcare
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Miami, FL 33178
CIK: 0001800682
ISIN: US13781Y2028
CUSIP: 13781Y103